Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities.

PURPOSE To study the role of mimecan, a member of the small leucine-rich proteoglycans (SLRPs) gene family and one of the major components of the cornea and other connective tissues, mice that lack a functional mimecan gene were generated and characterized. METHODS Mimecan-deficient mice were generated by gene-targeting using standard techniques. Mice were genotyped by Southern blot analysis. The absence of mimecan transcripts was confirmed by Northern blot analysis. Corneal clarity was examined by slit lamp biomicroscopy. The strength of the skin was evaluated using a biomechanical skin fragility test. Collagen morphology in cornea and skin preparations from mimecan-null and control wild-type mice was analyzed by transmission electron microscopy. The diameter of collagen fibrils in these tissues was determined by morphometric analysis. RESULTS Mice lacking mimecan appear to develop normally, are viable and fertile. In a controlled laboratory environment they do not display an evident pathological phenotype compared to wild type mice. Examination of corneal clarity and measurements of corneal thickness show no significant changes in the cornea. However, a skin fragility test revealed a moderate reduction in the tensile strength of skin from mutant mice. Ultrastructural analyses show, on average, thicker collagen fibrils in both corneal and skin preparations from mimecan-null mice. Collagen fibrils from the cornea of mutant mice show an average diameter of 31.84+/-0.322 nm, versus 22.40+/-0.296 nm in their wild type litter-mates. The most pronounced increase in collagen fibril diameter was found in the skin of mimecan-null mice, who demonstrated an average diameter of 130.33+/-1.769 nm, versus 78.82+/-1.157 nm in the wild type mice. In addition, size variability and altered collagen morphology was detected in dorsal and tail skin preparations from the mutant mice. CONCLUSIONS The results of the present study demonstrate that mimecan, similar to other members of the SLRP gene family, has a role in regulating collagen fibrillogenesis in vivo. Further studies, such as functional challenges, an evaluation of potential compensation by other proteins (including members of the SLRP family), and generation of double-knockouts will be necessary to fully uncover physiological functions of mimecan in mice.

[1]  P. Byers Ehlers-Danlos syndrome: recent advances and current understanding of the clinical and genetic heterogeneity. , 1994, The Journal of investigative dermatology.

[2]  L. Madisen,et al.  Molecular cloning of a novel bone-forming compound: osteoinductive factor. , 1990, DNA and cell biology.

[3]  E. Tasheva,et al.  Fibroblast Growth Factor-2 Promotes Keratan Sulfate Proteoglycan Expression by Keratocytes in Vitro * , 2000, The Journal of Biological Chemistry.

[4]  K. Prydz,et al.  Synthesis and sorting of proteoglycans. , 2000, Journal of cell science.

[5]  Renato V. Iozzo,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.

[6]  E. Thonar,et al.  Altered Fine Structures of Corneal and Skeletal Keratan Sulfate and Chondroitin/Dermatan Sulfate in Macular Corneal Dystrophy* , 2001, The Journal of Biological Chemistry.

[7]  Terry Magnuson,et al.  Lumican Regulates Collagen Fibril Assembly: Skin Fragility and Corneal Opacity in the Absence of Lumican , 1998, The Journal of cell biology.

[8]  E. Tasheva Analysis of the promoter region of human mimecan gene. , 2002, Biochimica et biophysica acta.

[9]  J. L. Bobbitt,et al.  Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors. , 1996, European journal of pharmacology.

[10]  E. Tasheva,et al.  Differential Splicing and Alternative Polyadenylation Generate Multiple Mimecan mRNA Transcripts* , 1997, The Journal of Biological Chemistry.

[11]  J. Hassell,et al.  Expression of the keratan sulfate proteoglycans lumican, keratocan and osteoglycin/mimecan during chick corneal development. , 2000, Experimental eye research.

[12]  N. Burrows,et al.  Ehlers-Danlos syndrome has varied molecular mechanisms. , 1997, Journal of medical genetics.

[13]  J. Osbourn,et al.  Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[14]  F. Reinholt,et al.  Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon* , 1999, The Journal of Biological Chemistry.

[15]  E. Schönherr,et al.  Critical Role of Glutamate in a Central Leucine-rich Repeat of Decorin for Interaction with Type I Collagen* , 1997, The Journal of Biological Chemistry.

[16]  C. Kublin,et al.  Proteoglycan changes during restoration of transparency in corneal scars. , 1983, Archives of biochemistry and biophysics.

[17]  D. Heinegård,et al.  Collagen binding proteins. , 2001, Osteoarthritis and cartilage.

[18]  A. Oldberg,et al.  Abnormal collagen fibrils in tendons of biglycan/fibromodulin‐deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  L. Svensson,et al.  Fibromodulin and lumican bind to the same region on collagen type I fibrils , 2000, FEBS letters.

[20]  J. Moreau,et al.  Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Iozzo,et al.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.

[22]  M. Rudnicki,et al.  Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.

[23]  Oldberg,et al.  Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 (*) , 1995, The Journal of Biological Chemistry.

[24]  G. Conrad,et al.  Immunoanalysis of keratan sulfate proteoglycan from corneal scars. , 1988, Investigative ophthalmology & visual science.

[25]  B. Spooner,et al.  Basal lamina anionic sites in the embryonic submandibular salivary gland: resolution and distribution using ruthenium red and polyethyleneimine as cationic probes. , 1986, European journal of cell biology.

[26]  R. Iozzo The Biology of the Small Leucine-rich Proteoglycans , 1999, The Journal of Biological Chemistry.

[27]  K. Kimata,et al.  Molecular cloning of the mouse osteoglycin-encoding gene. , 1995, Gene.

[28]  E. Tasheva,et al.  Mimecan, the 25-kDa Corneal Keratan Sulfate Proteoglycan, Is a Product of the Gene Producing Osteoglycin* , 1997, The Journal of Biological Chemistry.

[29]  S. Saika,et al.  Role of Lumican in the Corneal Epithelium during Wound Healing* , 2000, The Journal of Biological Chemistry.

[30]  J. Krachmer,et al.  Macular corneal dystrophy: failure to synthesize a mature keratan sulfate proteoglycan. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Tasheva,et al.  Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site. , 2001, Biochimica et biophysica acta.

[32]  J. Hassell,et al.  Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. , 1993, Experimental eye research.

[33]  E. Tasheva,et al.  Assignment1 of mimecan gene (OGN) to human chromosome band 9q22 by in situ hybridization , 2000, Cytogenetic and Genome Research.

[34]  E. Tasheva,et al.  The Bovine Mimecan Gene , 1999, The Journal of Biological Chemistry.